Deleterious vascular effects of indoxyl sulfate and reversal by oral adsorbent AST-120
- PMID: 26408929
- DOI: 10.1016/j.atherosclerosis.2015.09.019
Deleterious vascular effects of indoxyl sulfate and reversal by oral adsorbent AST-120
Abstract
Background: In chronic kidney disease (CKD), blood vessels are permanently exposed to uremic toxins such as indoxyl sulfate (IS). We hypothesized that IS could alter vascular tone and that reducing its serum concentration could be beneficial.
Design: We studied acute and longer-term effects of IS and AST-120, an oral charcoal adsorbent, on vascular reactivity, endothelium integrity and expression of adhesion molecules VCAM-1 and ICAM-1 in aortic rings of normal and uremic wild type (WT) mice in vitro, and the cardiovascular effects of AST-120 in both WT and apoE-/- mice with CKD in vivo.
Results: In vitro, 1.0 mM IS acutely reduced vascular relaxation (64% for IS 1.0 mM vs. 80% for control, p < 0.05). The effect was more marked after 4 days exposure (39% for IS 1.0 mM 4 days; p < 0.001, prolonged vs. acute exposure), and was associated with endothelial cell loss and upregulation of ICAM-1/VCAM-1 expression. In vitro, AST-120 restored normal vascular function and prevented IS induced endothelial cell loss and ICAM-1/VCAM-1 upregulation. In vivo, AST-120 treatment of CKD mice (1) improved vascular relaxation (72% vs. 48% maximal relaxation in treated vs. untreated mice, p < 0.001), (2) reduced aortic VCAM-1 and ICAM-1 expression, (3) decreased aorta systolic expansion rate (9 ± 3% CKD vs. 14 ± 3% CKD + AST-120, p < 0.02), and (4) prevented the increase in pulse wave velocity (3.56 ± 0.17 m/s CKD vs. 3.10 ± 0.08 m/s CKD + AST-120, p < 0.006). Similar changes were observed in apoE-/- mice.
Conclusion: IS appears to be an important contributor to the vascular dysfunction associated with CKD. AST-120 treatment ameliorates this dysfunction, possibly via a decrease in serum IS concentration.
Keywords: AST-120; CKD; Endothelial dysfunction; Indoxyl sulfate; Mouse.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
Oral Charcoal Adsorbents Attenuate Neointima Formation of Arteriovenous Fistulas.Toxins (Basel). 2020 Apr 8;12(4):237. doi: 10.3390/toxins12040237. Toxins (Basel). 2020. PMID: 32276394 Free PMC article.
-
Reduction of indoxyl sulfate by AST-120 attenuates monocyte inflammation related to chronic kidney disease.J Leukoc Biol. 2013 Jun;93(6):837-45. doi: 10.1189/jlb.0112023. Epub 2013 Jan 29. J Leukoc Biol. 2013. PMID: 23362306
-
The protein metabolite hypothesis, a model for the progression of renal failure: an oral adsorbent lowers indoxyl sulfate levels in undialyzed uremic patients.Kidney Int Suppl. 1997 Nov;62:S23-8. Kidney Int Suppl. 1997. PMID: 9350673
-
Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120.Toxins (Basel). 2018 Sep 11;10(9):367. doi: 10.3390/toxins10090367. Toxins (Basel). 2018. PMID: 30208594 Free PMC article. Review.
-
Indoxyl sulfate is a nephro-vascular toxin.J Ren Nutr. 2010 Sep;20(5 Suppl):S2-6. doi: 10.1053/j.jrn.2010.05.002. J Ren Nutr. 2010. PMID: 20797565 Review.
Cited by
-
How do Uremic Toxins Affect the Endothelium?Toxins (Basel). 2020 Jun 20;12(6):412. doi: 10.3390/toxins12060412. Toxins (Basel). 2020. PMID: 32575762 Free PMC article. Review.
-
Acute kidney disease in mice is associated with early cardiovascular dysfunction.Ren Fail. 2024 Dec;46(2):2415510. doi: 10.1080/0886022X.2024.2415510. Epub 2024 Oct 18. Ren Fail. 2024. PMID: 39422224 Free PMC article.
-
Uremic Vascular Calcification: The Pathogenic Roles and Gastrointestinal Decontamination of Uremic Toxins.Toxins (Basel). 2020 Dec 21;12(12):812. doi: 10.3390/toxins12120812. Toxins (Basel). 2020. PMID: 33371477 Free PMC article. Review.
-
The role of gut-dependent molecule trimethylamine N-oxide as a novel _target for the treatment of chronic kidney disease.Int Urol Nephrol. 2023 Jul;55(7):1747-1756. doi: 10.1007/s11255-023-03500-9. Epub 2023 Feb 16. Int Urol Nephrol. 2023. PMID: 36797553 Review.
-
Serum microRNAs are altered in various stages of chronic kidney disease: a preliminary study.Clin Kidney J. 2017 Feb;10(1):30-37. doi: 10.1093/ckj/sfw060. Epub 2016 Jul 4. Clin Kidney J. 2017. Retraction in: Clin Kidney J. 2017 Aug;10(4):578. doi: 10.1093/ckj/sfx068 PMID: 28643818 Free PMC article. Retracted.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous